Acquisition

Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech

March 09, 2010

Abbott will acquire Facet for $27 per share in cash
 

Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash

March 01, 2010

Astellas to build a world-class oncology platform
 

Cephalon Exercises its Option to Acquire Ception Therapeutics

February 23, 2010

Ception Delivers Positive Results from a Phase II Study of CINQUIL in Adult Eosinophilic Asthma
 

Merz to Complete Acquisition of BioForm Medical

February 19, 2010

Creates a Global Leader in Medical Aesthetics
 

Abbott Completes Acquisition of Solvay Pharmaceuticals

February 16, 2010

Abbott Pays $6.2 Billion for Solvay Pharmaceuticals
 

BioMarin to Acquire LEAD Therapeutics

February 04, 2010

Key Asset is LT-673
 

Enzon Completes Sale of Specialty Pharmaceutical Business

January 29, 2010

Enzon received $300 million in cash
 

QuantRx Biomedical to Acquire NuRx Pharmaceuticals

January 29, 2010

Combination Strengthens Financial and Competitive Position
 

Ligand Completes Acquisition of Metabasis

January 28, 2010

Ligand gains a fully funded partnership with Roche
 

Ethicon Completes Acquisition of Acclarent

January 20, 2010

Opportunity to Create New Growth Platform in Surgical ENT Market
 

Gambro Announces Agreement to Acquire CHF Solutions, Inc.

January 20, 2010

Developer of the Aquadex FlexFlow system
 

Celgene Completes Acquisition of Gloucester Pharmaceuticals

January 15, 2010

Transaction completed for $340 million in cash with additional milestone opportunities of up to $300 million
 

Eisai Completes Acquisition of AkaRx, Inc.

January 06, 2010

Continues Development of AKR-501 for Thrombocytopenia
 

Anika Therapeutics Acquires Fidia Advanced Biopolymers

December 31, 2009

A Leading Innovator in Hyaluronic Acid Based Tissue Engineered Products
 

Ligand Completes Neurogen Acquisition

December 23, 2009

Ligand gains a fully funded partnership with Merck & Co.
 

Sanofi-aventis to Acquire Chattem Inc., Creating a Strong U.S. Consumer Healthcare Platform

December 21, 2009

Chattem to lead sanofi-aventis' U.S. consumer health division
 

Myriad Pharmaceuticals to Acquire Javelin Pharmaceuticals

December 18, 2009

Creates Pipeline With Potential Near-Term Product Launch of Dyloject(TM)
 

Ethicon Announces Definitive Agreement to Acquire Acclarent

December 16, 2009

Acclarent's Broad Product Portfolio Provides New Growth Platform in ENT
 

Adamis Pharmaceuticals Announces Signing of Definitive Merger Agreement

December 07, 2009

Adamis to acquire La Jolla Pharmaceutical Company
 

Watson Completes Acquisition of Arrow Group

December 02, 2009

Watson acquired the Arrow Group for a cash payment of $1.05 billion
 

Enzon Announces Agreement to Sell Specialty Pharmaceutical Business

November 09, 2009

sigma-tau to acquire business for approximately $327 million in cash plus royalties
 

Abbott Completes Acquisition of Evalve, Inc.

November 02, 2009

Acquisition provides Abbott with a leading presence in non-surgical treatment for structural heart disease
 

Metabasis Announces Ligand to Acquire Metabasis for Cash and Contingent Value Rights

October 27, 2009

Ligand to Gain Fully Funded Partnership with Roche for Hepatitis and Promising Development-Stage Programs
 

Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer

October 26, 2009

Acquisition positions Boehringer Ingelheim among the world's top animal health companies
 

Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation

October 26, 2009

Deal will Provide Cephalon New Path Forward for Development of its Tumor Necrosis Factor Inhibitor
 

Merck and Schering-Plough Receive Approval From European Commission for Merger

October 23, 2009

Transaction expected to close in the fourth quarter of 2009
 

Abbott Completes Visiogen Acquisition

October 21, 2009

Visiogen boosts Abbott's presence in the vision care segment
 

Dainippon Sumitomo Pharma Co., Ltd. Completes Acquisition of Sepracor Inc.

October 21, 2009

DSP acquires Sepracor for US$23.00 per share in cash
 

OXiGENE to Acquire VaxGen in a Stock-for-Stock Merger

October 15, 2009

Acquisition to Add Approximately $33 Million in Cash to OXiGENE's Balance Sheet